Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla et al. · The Lancet · 2012 · 2K citations · Full text

Metastatic Soft-tissue Sarcoma, Placebo-controlled Phase 3, Medicine +8

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Stefan Sleijfer, Isabelle Ray‐Coquard, Zsuzsa Pápai et al. · Journal of Clinical Oncology · 2009 · 674 citations · Full text

Oncology, Angiogenesis, Bone Sarcoma Group +14

Localized Extremity Soft Tissue Sarcoma: Improved Knowledge With Unchanged Survival Over Time

Jürgen Weitz, Christina R. Antonescu, Murray F. Brennan · Journal of Clinical Oncology · 2003 · 363 citations

Synovial sarcoma

Peter Bergh, Jeanne M. Meis‐Kindblom, F. Gherlinzoni et al. · Cancer · 1999 · 294 citations · Full text

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

Gerald Rosen, Charles Forscher, Susan Lowenbraun et al. · Cancer · 1994 · 273 citations